DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 94 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Monolithisch India Limited — Analysts/Institutional Investor Meet/Con. Call Updates

NSE 1 hr ago·20 Oct 2026, 5:53 am

Monolithisch India

Monolithisch India Limited has filed a notice with the stock exchange indicating the dates and times for an upcoming analysts and institutional investor meeting and a conference call. The schedule will be posted on the exchange and the company's website.

Such sessions give the company a platform to present recent performance, strategic plans and any guidance, while allowing investors to ask questions directly. For retail investors, the meeting can provide clearer insight into revenue trends, upcoming projects, or potential risks that may not be evident from regular filings.

Investors should keep an eye on the actual meeting minutes or any transcript that follows, as any forward‑looking statements or changes in outlook could affect the stock. Monitoring subsequent price movement and any updates to guidance will help gauge market reaction.